Wellbutrin XL

Major Depressive Disorder

Wellbutrin XL is approved for the treatment of major depressive disorder (MDD) in adults. It is used to help improve mood and feelings of well-being by affecting certain natural chemicals in the brain. It is often prescribed for long-term management of depressive symptoms.

Seasonal Affective Disorder

This medication is also used to prevent seasonal affective disorder (SAD), which is a type of depression that occurs at the same time each year, typically during the autumn and winter months. For this condition, the medication is usually started in the fall before symptoms begin and continued through the early spring.

General Use

Wellbutrin XL is an extended-release version of bupropion, meaning the medicine is released slowly into the body over a 24-hour period. While other forms of bupropion may be used for different conditions, such as smoking cessation, Wellbutrin XL is specifically indicated for the treatment and prevention of depressive episodes.

Mechanism of Action

Wellbutrin XL belongs to a class of medications known as aminoketone antidepressants. While the exact way it works is not fully understood, it is believed to help restore the balance of certain natural chemicals in the brain called neurotransmitters.

Specifically, this medication affects two main chemicals:

• Norepinephrine: A chemical that plays a role in alertness and energy.
• Dopamine: A chemical associated with motivation and pleasure.

Wellbutrin XL acts as a norepinephrine-dopamine reuptake inhibitor (NDRI). This means it prevents the brain from reabsorbing these chemicals too quickly, making more of them available to send signals between nerve cells. Unlike many other common antidepressants, Wellbutrin XL does not significantly affect serotonin levels.

By increasing the availability of norepinephrine and dopamine, the medication is thought to help improve concentration, energy levels, and overall mood in people with depression.

Common Side Effects

Commonly reported side effects of Wellbutrin XL include:

• Dry mouth and sore throat
• Nausea, vomiting, stomach pain, or constipation
• Headache
• Dizziness
• Excessive sweating
• Shaking or tremors
• Loss of appetite and weight loss
• Trouble sleeping (insomnia)
• Fast or pounding heartbeat
• Ringing in the ears
• Changes in the sense of taste
• Frequent urination

Serious Side Effects

Contact a healthcare provider immediately if you experience any of the following serious symptoms:

• Seizures (convulsions)
• Confusion, hallucinations, or irrational fears
• Chest pain
• Muscle or joint pain
• Severe skin rash, itching, blisters, or hives
• Swelling of the face, throat, tongue, eyes, hands, or feet
• Difficulty breathing or swallowing
• Hoarseness
• Vision changes, such as seeing halos around lights, eye pain, or redness

Suicidal Thoughts and Behaviors

Wellbutrin XL and other antidepressant medications may increase the risk of suicidal thoughts or actions, especially in children, teenagers, and young adults. This risk is highest during the first few months of treatment or when the dose is adjusted. Caregivers and family members should monitor for sudden changes in mood, behavior, or feelings, such as worsening depression, anxiety, or agitation.

Seizure Risk

This medication is associated with a dose-related risk of seizures. The risk increases with higher doses or in the presence of certain pre-existing conditions. Wellbutrin XL should not be used by individuals who:

• Have a current seizure disorder or a history of seizures.
• Have or have had an eating disorder, such as anorexia or bulimia.
• Are undergoing abrupt discontinuation of alcohol, benzodiazepines, barbiturates, or antiepileptic drugs.

Neuropsychiatric Reactions

Some patients may experience serious mental health changes while taking this medication. These can include agitation, hostility, aggressiveness, hallucinations, paranoia, or delusions. It may also trigger a manic episode in individuals with undiagnosed bipolar disorder. Monitoring for these symptoms is essential throughout the course of treatment.

Other Important Precautions

• Hypertension: This medication can cause an increase in blood pressure. Blood pressure should be monitored regularly, particularly when Wellbutrin XL is used in combination with nicotine replacement therapy.
• Angle-Closure Glaucoma: The use of this drug may trigger an episode of angle-closure glaucoma in people with anatomically narrow eye angles. Symptoms may include eye pain, swelling, or vision changes.
• Drug Interactions: Wellbutrin XL must not be used within 14 days of taking a monoamine oxidase inhibitor (MAOI) due to the risk of severe, potentially life-threatening reactions.
• Allergic Reactions: Severe skin reactions and anaphylaxis have been reported. Treatment should be stopped if a skin rash or other signs of an allergic reaction occur.

Pregnancy

The safety of Wellbutrin XL during pregnancy has not been fully established. While some studies have been conducted, the evidence regarding potential risks to an unborn baby is limited. Healthcare providers generally advise using this medication during pregnancy only if it is clearly needed and the benefits to the parent outweigh the potential risks to the fetus.

If you are pregnant or planning to become pregnant, it is important to discuss your treatment plan with a doctor. They can provide guidance on managing your condition while minimizing risks. Do not start or stop taking this medication without professional medical advice.

Breastfeeding

Wellbutrin XL passes into breast milk. There is a possibility that a nursing infant could experience side effects from exposure to the medication. Because of this, it is important to talk to a healthcare provider if you are breastfeeding or planning to breastfeed while taking this medication.

A clinician can help you weigh the benefits of breastfeeding against the potential risks to the infant and may monitor the baby for any unusual symptoms or changes in behavior.

Available Forms

Wellbutrin XL is provided in the following form:

• Extended-release oral tablets: This version of the medication is formulated to release the active ingredient gradually over an extended period.

These tablets must be swallowed whole. They should not be crushed, chewed, or divided, as doing so can cause the medication to be released too quickly into the body.

FDA Approval and Indications

Wellbutrin XL is approved by the U.S. Food and Drug Administration (FDA) for the treatment of major depressive disorder (MDD) and the prevention of seasonal affective disorder (SAD), also known as seasonal depression. It is an extended-release formulation of bupropion hydrochloride intended for once-daily administration.

Boxed Warning

The FDA requires a boxed warning for Wellbutrin XL and all other antidepressant medications. This warning indicates that antidepressants may increase the risk of suicidal thoughts and behaviors in children, adolescents, and young adults up to age 24. Patients of all ages should be monitored closely for worsening depression, suicidal ideation, or unusual changes in behavior, particularly during the first few months of treatment or following dosage adjustments.

Regulatory History and Safety

Bupropion was first approved by the FDA in 1985. While Wellbutrin XL is approved for adults, it is not approved for use in pediatric patients. Regulatory guidance also emphasizes the importance of screening patients for bipolar disorder before starting treatment, as antidepressants can trigger manic or mixed episodes in individuals with this condition. The FDA has also issued communications regarding the risk of seizures, which is dose-related, and neuropsychiatric symptoms such as agitation or hostility.

Weight Changes and Wellbutrin XL

Weight loss is a commonly reported side effect for people taking Wellbutrin XL. While many antidepressants are associated with weight gain, bupropion (the active ingredient in Wellbutrin XL) is often associated with weight loss or a neutral effect on body weight.

Appetite and Weight Effects

The impact of Wellbutrin XL on weight can vary, but common observations include:

• Decreased Appetite: Some individuals report a reduction in hunger or changes in how food tastes while taking this medication.
• Weight Reduction: Clinical data suggests that a percentage of people taking bupropion may lose weight during their treatment, particularly in the initial months.
• Individual Variation: Not everyone will lose weight; some people may experience no change, and a small number of people may experience weight gain.

Medical Considerations

Wellbutrin XL is primarily indicated for the treatment of major depressive disorder and seasonal affective disorder. It is not specifically approved by the FDA as a weight-loss medication. If you notice significant or unexpected changes in your weight or appetite while taking this medication, it is important to consult a healthcare professional to monitor your health and ensure the medication is appropriate for your needs.